Logo image of ALSGD.PA

SPINEGUARD SA (ALSGD.PA) Stock Fundamental Analysis

EPA:ALSGD - FR0011464452 - Common Stock

0.0842 EUR
0 (-1.64%)
Last: 9/3/2025, 7:00:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ALSGD. ALSGD was compared to 57 industry peers in the Health Care Equipment & Supplies industry. ALSGD may be in some trouble as it scores bad on both profitability and health. ALSGD has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALSGD has reported negative net income.
In the past year ALSGD has reported a negative cash flow from operations.
ALSGD had negative earnings in each of the past 5 years.
ALSGD had a negative operating cash flow in each of the past 5 years.
ALSGD.PA Yearly Net Income VS EBIT VS OCF VS FCFALSGD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1M -2M -3M -4M

1.2 Ratios

ALSGD has a Return On Assets of -37.45%. This is amonst the worse of the industry: ALSGD underperforms 80.70% of its industry peers.
Looking at the Return On Equity, with a value of -78.95%, ALSGD is doing worse than 78.95% of the companies in the same industry.
Industry RankSector Rank
ROA -37.45%
ROE -78.95%
ROIC N/A
ROA(3y)-32.05%
ROA(5y)-28.87%
ROE(3y)-64.95%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALSGD.PA Yearly ROA, ROE, ROICALSGD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10K 20K 30K

1.3 Margins

The Gross Margin of ALSGD (70.80%) is better than 78.95% of its industry peers.
In the last couple of years the Gross Margin of ALSGD has declined.
ALSGD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 70.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.62%
GM growth 5Y-2.09%
ALSGD.PA Yearly Profit, Operating, Gross MarginsALSGD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

0

2. Health

2.1 Basic Checks

ALSGD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALSGD has more shares outstanding
Compared to 5 years ago, ALSGD has more shares outstanding
The debt/assets ratio for ALSGD is higher compared to a year ago.
ALSGD.PA Yearly Shares OutstandingALSGD.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ALSGD.PA Yearly Total Debt VS Total AssetsALSGD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

ALSGD has an Altman-Z score of -6.26. This is a bad value and indicates that ALSGD is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ALSGD (-6.26) is worse than 85.96% of its industry peers.
ALSGD has a Debt/Equity ratio of 0.52. This is a neutral value indicating ALSGD is somewhat dependend on debt financing.
The Debt to Equity ratio of ALSGD (0.52) is worse than 61.40% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Altman-Z -6.26
ROIC/WACCN/A
WACC8.19%
ALSGD.PA Yearly LT Debt VS Equity VS FCFALSGD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M

2.3 Liquidity

A Current Ratio of 0.97 indicates that ALSGD may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.97, ALSGD is doing worse than 84.21% of the companies in the same industry.
ALSGD has a Quick Ratio of 0.97. This is a bad value and indicates that ALSGD is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ALSGD (0.69) is worse than 73.68% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.69
ALSGD.PA Yearly Current Assets VS Current LiabilitesALSGD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 42.95% over the past year.
The Revenue has been growing slightly by 7.77% in the past year.
ALSGD shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.41% yearly.
EPS 1Y (TTM)42.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.08%
Revenue 1Y (TTM)7.77%
Revenue growth 3Y1.8%
Revenue growth 5Y-7.41%
Sales Q2Q%5.94%

3.2 Future

The Earnings Per Share is expected to grow by 29.42% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALSGD will show a small growth in Revenue. The Revenue will grow by 1.70% on average per year.
EPS Next Y83.22%
EPS Next 2Y35.36%
EPS Next 3Y29.42%
EPS Next 5YN/A
Revenue Next Year-15.4%
Revenue Next 2Y-7.32%
Revenue Next 3Y1.7%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALSGD.PA Yearly Revenue VS EstimatesALSGD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M 8M 10M
ALSGD.PA Yearly EPS VS EstimatesALSGD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALSGD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ALSGD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALSGD.PA Price Earnings VS Forward Price EarningsALSGD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALSGD.PA Per share dataALSGD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 -0.04 0.06

4.3 Compensation for Growth

ALSGD's earnings are expected to grow with 29.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.36%
EPS Next 3Y29.42%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALSGD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SPINEGUARD SA

EPA:ALSGD (9/3/2025, 7:00:00 PM)

0.0842

0 (-1.64%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-15 2025-04-15
Earnings (Next)09-10 2025-09-10
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.31M
Analysts84.44
Price Target0.64 (660.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)79.87%
EPS NY rev (3m)79.87%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-23.36%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.14
P/FCF N/A
P/OCF N/A
P/B 1.36
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.07
BVpS0.06
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -37.45%
ROE -78.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 70.8%
FCFM N/A
ROA(3y)-32.05%
ROA(5y)-28.87%
ROE(3y)-64.95%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.62%
GM growth 5Y-2.09%
F-Score4
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 117.97%
Cap/Sales 7.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.97
Quick Ratio 0.69
Altman-Z -6.26
F-Score4
WACC8.19%
ROIC/WACCN/A
Cap/Depr(3y)225.04%
Cap/Depr(5y)170.18%
Cap/Sales(3y)14.39%
Cap/Sales(5y)11.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.08%
EPS Next Y83.22%
EPS Next 2Y35.36%
EPS Next 3Y29.42%
EPS Next 5YN/A
Revenue 1Y (TTM)7.77%
Revenue growth 3Y1.8%
Revenue growth 5Y-7.41%
Sales Q2Q%5.94%
Revenue Next Year-15.4%
Revenue Next 2Y-7.32%
Revenue Next 3Y1.7%
Revenue Next 5YN/A
EBIT growth 1Y25.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year25.26%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y41.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.99%
OCF growth 3YN/A
OCF growth 5YN/A